Published in Cancer Weekly, August 17th, 2010
"Median follow-up: 33.03 months. Positive HER-2 expression was found in 10 cases and cytoplasmic p-AKT expression in 84...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.